跳至主要内容
临床试验/NCT00005654
NCT00005654已完成不适用

Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome

National Center for Research Resources (NCRR)0 个研究点目标入组 88 人开始时间: 2000年1月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
88

研究概览

简要总结

OBJECTIVES:

I. Determine whether reduction of serum insulin levels by metformin increases ovulatory response to clomiphene or spontaneous ovulation in obese women with polycystic ovary syndrome.

详细描述

PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled, multicenter study. Patients are randomized to one of two treatment arms.

Patients receive oral metformin (arm I) or oral placebo (arm II) three times daily for 8 weeks. All patients who do not ovulate by day 28 receive oral clomiphene citrate daily on days 36-40.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •PROTOCOL ENTRY CRITERIA:
  • •-Disease Characteristics--
  • •Obese women with chronic anovulation due to polycystic ovary syndrome (PCOS)
  • •Must have oligoamenorrhea and hyperandrogenemia
  • •-Prior/Concurrent Therapy--
  • •At least 2 months since prior standard therapy (including over the counter drugs) At least 2 months since prior investigational agents
  • •-Patient Characteristics--
  • •Hematopoietic: Hematocrit greater than 38%
  • •Hepatic: Liver function normal No clinically significant hepatic disease
  • •Renal: No clinically significant renal disease Creatinine less than 1.4 mg/dL No proteinuria
  • •Cardiovascular: No clinically significant cardiac disease
  • •Pulmonary: No clinically significant pulmonary disease
  • •Hormonal: Thyroid function normal Prolactin normal Fasting 17 alpha-hydroxy progesterone less than 200 mg/dL OR No late onset adrenal hyperplasia 21 alpha-hydroxylase deficiency
  • •Other: Not pregnant Negative pregnancy test Fertile patients must use effective contraception No diabetes mellitus No clinically significant neurologic, psychiatric, infectious, neoplastic, or metabolic disease No clinically significant malignant disease except nonmelanomatous skin cancer At least 1 year since any prior drug abuse or alcoholism

排除标准

  • 未提供

研究者

发起方
National Center for Research Resources (NCRR)
申办方类型
Nih

相似试验